Realcan Pharmaceutical Group Co., Ltd. (SHE:002589)

China flag China · Delayed Price · Currency is CNY
3.250
+0.030 (0.93%)
Apr 29, 2026, 3:04 PM CST
15.66%
Market Cap 4.82B
Revenue (ttm) 7.25B
Net Income (ttm) 14.35M
Shares Out 1.48B
EPS (ttm) 0.01
PE Ratio 336.05
Forward PE n/a
Dividend 0.00 (0.06%)
Ex-Dividend Date n/a
Volume 45,481,267
Average Volume 127,491,202
Open 3.210
Previous Close 3.220
Day's Range 3.160 - 3.260
52-Week Range 2.770 - 4.690
Beta 0.37
RSI 47.46
Earnings Date Apr 23, 2026

About SHE:002589

Realcan Pharmaceutical Group Co., Ltd. sells medicines, medical devices, and medical consumables to medical institutions in China. It operates through the Drug and Equipment Distribution, In Vitro Diagnostics, Pharmaceutical Logistics, Traditional Chinese Medicine, and Microbiome Medicine segments. The company engages in the processing, manufacture, sale, and wholesale of Chinese medicinal materials, herbal medicine, and patent medicine. It is also involved in the wholesale of biochemical, psychotropic, narcotic, and toxic drugs for medical use... [Read more]

Sector Healthcare
Founded 2004
Employees 2,897
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002589
Full Company Profile

Financial Performance

In 2025, SHE:002589's revenue was 7.30 billion, a decrease of -8.42% compared to the previous year's 7.97 billion. Earnings were 16.07 million, a decrease of -22.07%.

Financial Statements

News

There is no news available yet.